BioCardia, Inc.
- BCDA
- NASDAQ
- Biotechnology
- Cardiac Cell Therapy
- Regenerative Medicine
$0.90
Today −2.46%Quote Oct 19, 2026, 08:00 PM UTC
−23.29%over the last month
Max drawdown −23.3%From 1-month high −23.3%3 months −2.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About BioCardia
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
17
Market value
$13.6M
Quote Oct 19
Floor
$0.87
3.5% below price
Resistance
$0.94
5.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BCDAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free